Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
KLIN.SW Stock Summary
Top 10 Correlated ETFs
KLIN.SW
In the News
KLIN.SW Financial details
Company Rating
Buy
Market Cap
155.58M
Income
-25.36M
Revenue
212.09M
Book val./share
-
Cash/share
-
Dividend
0.4
Dividend %
2.18%
Employees
1.23K
Optionable
No
Shortable
Yes
Earnings
16 Jun 2023
P/E
7.81
Forward P/E
58.67
PEG
4.45
P/S
0.52
P/B
1.28
P/C
-
P/FCF
-62
Quick Ratio
0.07
Current Ratio
1.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.88
EPS next Y
0.3
EPS next Q
-
EPS this Y
-195.92%
EPS next Y
-110.42%
EPS next 5Y
-102.31%
EPS last 5Y
1.33%
Revenue last 5Y
2.12%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-5.96%
SMA50
-5.46%
SMA100
-9.89%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
18%
ROC
0.1%
Gross Margin
54%
Oper. Margin
5%
Profit Margin
7%
Payout
-
Shs Outstand
8.84M
Shs Float
3.87M
-
-
-
-
Target Price
-
52W Range
11.35-20.2
52W High
-12%
52W Low
+60%
RSI
45.21
Rel Volume
1.04
Avg Volume
2.65K
Volume
2.75K
Perf Week
2.92%
Perf Month
-7.85%
Perf Quarter
-3.03%
Perf Half Y
15.03%
-
-
-
-
Beta
1.69519
-
-
Volatility
0.19%, 0.57%
Prev Close
-1.12%
Price
17.6
Change
1.44%
KLIN.SW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 31.81 | 23.99 | 17.95 | 17.94 | 34.95 | |
Net income per share | 2.2 | -2.87 | -0.82 | -2.45 | 2.35 | |
Operating cash flow per share | 3.15 | -0.25 | 0.86 | -6.17 | 1.78 | |
Free cash flow per share | 2.27 | -0.89 | 0.44 | -7.48 | -0.3 | |
Cash per share | 3.28 | 4.38 | 2.55 | 0.87 | 0.99 | |
Book value per share | 18.64 | 14.88 | 13.63 | 11.85 | 14.32 | |
Tangible book value per share | 18.44 | 14.72 | 13.51 | 11.75 | 14.24 | |
Share holders equity per share | 18.64 | 14.88 | 13.63 | 11.85 | 14.32 | |
Interest debt per share | 0.81 | 3.43 | 0.06 | 0.07 | 0.14 | |
Market cap | 260.21M | 81.46M | 197.56M | 138.46M | 151.31M | |
Enterprise value | 236.24M | 45.7M | 174.98M | 130.74M | 142.59M | |
P/E ratio | 13.54 | -3.21 | -27.09 | -6.39 | 7.29 | |
Price to sales ratio | 0.94 | 0.38 | 1.24 | 0.87 | 0.49 | |
POCF ratio | 9.43 | -36.66 | 25.94 | -2.54 | 9.64 | |
PFCF ratio | 13.13 | -10.37 | 50.85 | -2.09 | -57.86 | |
P/B Ratio | 1.6 | 0.62 | 1.64 | 1.32 | 1.2 | |
PTB ratio | 1.6 | 0.62 | 1.64 | 1.32 | 1.2 | |
EV to sales | 0.85 | 0.22 | 1.1 | 0.82 | 0.46 | |
Enterprise value over EBITDA | 6.98 | -3.1 | -45.52 | -9.03 | 6.82 | |
EV to operating cash flow | 8.56 | -20.57 | 22.97 | -2.4 | 9.08 | |
EV to free cash flow | 11.92 | -5.82 | 45.04 | -1.98 | -54.53 | |
Earnings yield | 0.07 | -0.31 | -0.04 | -0.16 | 0.14 | |
Free cash flow yield | 0.08 | -0.1 | 0.02 | -0.48 | -0.02 | |
Debt to equity | 0.04 | 0.23 | 0 | 0 | 0 | |
Debt to assets | 0.03 | 0.12 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.71 | 2.42 | 5.87 | 0.53 | -0.42 | |
Current ratio | 2.64 | 1.94 | 1.96 | 1.48 | 1.65 | |
Interest coverage | 46.41 | -64.03 | -24.18 | -26.24 | 13.57 | |
Income quality | 1.44 | 0.09 | -1.04 | 2.52 | 0.76 | |
Dividend Yield | 0 | 0.1 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.32 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
Capex to operating cash flow | -0.28 | 2.53 | -0.49 | 0.21 | -1.17 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.07 | -0.06 | |
Capex to depreciation | -1.22 | -0.97 | -0.75 | -2.54 | -4.24 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 30.35 | 30.99 | 15.91 | 25.57 | 27.51 | |
ROIC | 0.13 | -0.14 | -0.08 | -0.17 | 0.13 | |
Return on tangible assets | 0.08 | -0.1 | -0.03 | -0.08 | 0.07 | |
Graham Net | -2.55 | -3.4 | -3.8 | -10.7 | -10.22 | |
Working capital | 117.77M | 88.16M | 75.4M | 69.2M | 81.99M | |
Tangible asset value | 161.26M | 130.14M | 119.4M | 103.89M | 125.88M | |
Net current asset value | 96.96M | 68.45M | 57.47M | 45.57M | 50.58M | |
Invested capital | 0.04 | 0.23 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 16.03M | 13.51M | 12.72M | 24.26M | 30.71M | |
Average inventory | 79.56M | 85.93M | 84.74M | 106.76M | 125.31M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 54.57 | 49.11 | 92.59 | 177.71 | 70.31 | |
Days of inventory on hand | 278.14 | 406.11 | 507.99 | 698.48 | 299.86 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 6.69 | 7.43 | 3.94 | 2.05 | 5.19 | |
Inventory turnover | 1.31 | 0.9 | 0.72 | 0.52 | 1.22 | |
ROE | 0.12 | -0.19 | -0.06 | -0.21 | 0.16 | |
Capex per share | -0.89 | -0.64 | -0.42 | -1.31 | -2.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q4
Metric | History | 2021-03-31 | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -22.58M | -20.19M | -7.72M | -12.27M | -8.72M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.96 | 1.3 | 1.48 | 1.54 | 1.65 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 75.4M | 38.17M | 69.2M | 73.62M | 81.99M | |
Tangible asset value | 119.4M | 79.35M | 103.89M | 108.71M | 125.88M | |
Net current asset value | 57.47M | 20.61M | 45.57M | 41.14M | 50.58M | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
KLIN.SW Frequently Asked Questions
What is Klingelnberg AG stock symbol ?
Klingelnberg AG is a CH stock and trading under the symbol KLIN.SW
What is Klingelnberg AG stock quote today ?
Klingelnberg AG stock price is $17.6 today.
Is Klingelnberg AG stock public?
Yes, Klingelnberg AG is a publicly traded company.